Previous MRI studies have reported that structural damage in SCA3 preceded the onset of clinical manifestations [7, 8], a pattern also observed in Huntington’s disease and familial amyotrophic lateral sclerosis [24, 25]. The gene discussed is ATXN3; the disease is juvenile Huntington disease.